The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas

Cancer

Volumn 92, Issue 10, 2001, Pages 2727-2732

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Cytokeratin 20; Cytokeratin 7; Mesothelioma; Metastasis; Pleura

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7;

ADENOCARCINOMA; ARTICLE; BILIARY TRACT TUMOR; BREAST CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLEURA MESOTHELIOMA; PLEURA METASTASIS; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; AUTOPSY; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; LUNG NEOPLASMS; MESOTHELIOMA; NEOPLASM METASTASIS; PLEURAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035889916     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011115)92:10<2727::AID-CNCR1627>3.0.CO;2-B     Document Type: Article

References (20)

1. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinomas metastatic to the pleura
2. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinomas in serous effusions
3. Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma and adenocarcinomas. Utility of combined E-cadherin and Calretinin immunostaining
4. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma
5. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions
6. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas
7. Value of Cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinomas
8. Anti-cytokeratin 5/6: A positive marker for epithelioid mesothelioma
9. Adenocarcinomas metastatic to the liver: The value of cytokeratins 20 and 7 in the search for unknown primary tumors
10. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary
11. Primary versus metastatic pulmonary adenocarcinoma: An immunohistochemical study using villin, cytokeratin 7 and 20
12. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
13. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract
14. Application of cytokeratin 7 and 20 immunohistochemistry to diagnostic pathology
15. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours
16. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissue
17. Use of monoclonal antibodies to keratin 7 in differential diagnosis of adenocarcinomas
18. Coordinate expression of cytokeratin 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma
19. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: A study of 123 cases
20. The cytokeratin profile of medullary carcinoma of the breast